This one has been a shell for a few years now and seems to be at its base. 150m shares on issue. A board restructure some time ago. And seemingly a bit more volume in the last few weeks. Could be a deal on its way.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor